Your browser doesn't support javascript.
loading
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate.
Mahler, Donald A; Ohar, Jill A; Barnes, Chris N; Moran, Edmund J; Pendyala, Srikanth; Crater, Glenn D.
Afiliação
  • Mahler DA; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire and Respiratory Services, Valley Regional Hospital, Claremont, New Hampshire.
  • Ohar JA; Wake Forest University Medical Center, Winston-Salem, North Carolina.
  • Barnes CN; Theravance Biopharma US, Inc., South San Francisco, California.
  • Moran EJ; Theravance Biopharma US, Inc., South San Francisco, California.
  • Pendyala S; Theravance Biopharma US, Inc., South San Francisco, California.
  • Crater GD; Theravance Biopharma US, Inc., South San Francisco, California.
Chronic Obstr Pulm Dis ; 6(4)2019 Oct 23.
Article em En | MEDLINE | ID: mdl-31647854
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2019 Tipo de documento: Article